Table 2.

Summary of identified significant SNPs.

	Chr	SNP	Pos	A1	A2	p-value
All-count prescription phenotype	1	rs709286	36,674,559	C	T	6.90E−12
	1	rs11164801	93,203,178	A	C	4.78E−09
	2	rs11680325	38,338,625	G	T	1.67E−11
	3	rs375170584	27,832,107	C	G	1.32E−08
	4	rs2902921	9,591,436	C	A	6.44E−19
	5	rs55905691	110,425,985	G	A	5.50E−09
	11	rs364139	4,306,665	G	T	2.38E−09
	14	rs2093210	60,957,279	T	C	5.87E−10
	17	rs12453884	27,860,606	C	T	6.94E−10
Seven or more prescriptions	2	rs11680325	38,338,625	G	T	1.44E−09
	4	rs2902921	9,591,436	C	A	1.62E−12
	14	rs2093210	60,957,279	T	C	3.83E−10
Six or more prescriptions	1	rs709286	36,674,559	C	T	1.10E−08
	2	rs11680325	38,338,625	G	T	3.60E−10
	4	rs2902921	9,591,436	C	A	1.47E−15
	11	rs364139	4,306,665	G	T	1.60E−09
	14	rs2093210	60,957,279	T	C	1.47E−09
Five or more prescriptions	1	rs709286	36,674,559	T	C	1.35E−11
	1	rs11164801	93,203,178	A	C	1.52E−08
	2	rs11680325	38,338,625	G	T	1.40E−10
	3	rs375170584	27,832,107	C	G	3.32E−08
	4	rs2902921	9,591,436	C	A	2.25E−18
	11	rs364139	4,306,665	G	T	1.52E−09
	14	rs2093210	60,957,279	T	C	1.83E−10
	17	rs12453884	27,860,606	C	T	6.14E−10
Four or more prescriptions	1	rs709286	36,674,559	T	C	1.09E−12
	1	rs11164801	93,203,178	A	C	2.68E−09
	2	rs11680325	38,338,625	G	T	1.21E−09
	4	rs2902921	9,591,436	C	A	1.02E−19
	11	rs9704423	4,323,143	G	A	7.70E−09
	14	rs2093210	60,957,279	T	C	8.40E−09
	17	rs12453884	27,860,606	C	T	5.14E−10
Three prescriptions	4	rs78121242	9,591,433	C	A	2.42E−08
Two prescriptions	4	rs78121242	9,591,433	C	A	2.10E−08
One prescription	4	rs13103207	9,603,672	C	T	2.24E−08